Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Return on Sales (2020 - 2022)

Historic Return on Sales for Therapeutics (RAPT) over the last 4 years, with Q1 2023 value amounting to 109.01%.

  • Therapeutics' Return on Sales fell 765900.0% to 109.01% in Q1 2023 from the same period last year, while for Mar 2023 it was 109.01%, marking a year-over-year decrease of 862800.0%. This contributed to the annual value of 56.19% for FY2022, which is 380400.0% down from last year.
  • Per Therapeutics' latest filing, its Return on Sales stood at 109.01% for Q1 2023, which was down 765900.0% from 56.19% recorded in Q4 2022.
  • Therapeutics' Return on Sales' 5-year high stood at 9.58% during Q3 2020, with a 5-year trough of 109.01% in Q1 2023.
  • Its 4-year average for Return on Sales is 28.6%, with a median of 19.31% in 2021.
  • In the last 5 years, Therapeutics' Return on Sales surged by 5400bps in 2021 and then tumbled by -765900bps in 2023.
  • Therapeutics' Return on Sales (Quarter) stood at 9.78% in 2020, then plummeted by -142bps to 23.72% in 2021, then plummeted by -137bps to 56.19% in 2022, then crashed by -94bps to 109.01% in 2023.
  • Its Return on Sales stands at 109.01% for Q1 2023, versus 56.19% for Q4 2022 and 34.73% for Q3 2022.